Evli (EVLI) Q3 2026 earnings summary

Executive summary

• 1–9/2026 net revenue rose 3% to €93.0M and operating profit rose 4% to €42.0M; AUM reached a record €22.9B.

• Recurring revenue grew 11% YoY and covered 142% of operating costs, up from 128%.

Financial highlights

• 1–9/2026 net commission income increased 5% to €89.8M; performance fees were €10.3M versus €12.7M, while own-investment income fell to €3.0M from €4.4M.

• 1–9/2026 profit for the period was €33.1M versus €32.0M; diluted EPS rose to €1.07 from €0.97.

• Q3/2026 net revenue was €27.8M versus €35.2M, operating profit €12.1M versus €18.0M, and net profit €9.7M versus €14.6M.

• 1–9/2026 operating costs including depreciation and impairment were €50.7M versus €49.9M; cost-income ratio was 0.55 in both periods.

• Fund-fee revenue was €64.0M versus €56.5M in 1–9/2026.

Outlook and guidance

• 2026 operating profit is expected to be clearly positive; the outlook was unchanged, supported by a strong market position, broad product range and client base.

• Comparability in H2 is affected by exceptionally high performance-based fees in H2 2025; market uncertainty may weigh on commission income and own-investment returns.

• Strategic priorities include growing client assets, strengthening international distribution, developing alternative investments and improving operating efficiency.